BioLife Solutions Inc. (BLFS) is a publicly traded Healthcare sector company. As of May 21, 2026, BLFS trades at $24.00 with a market cap of $1.09B and a P/E ratio of -401.10. BLFS moved +4.43% today. Year to date, BLFS is -5.18%; over the trailing twelve months it is +5.22%. Its 52-week range spans $17.86 to $29.62. Analyst consensus is strong buy with an average price target of $33.00. Rallies surfaces BLFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BLFS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BLFS recently traded at $24.00. Market cap is $1.09B. P/E ratio is -401.10. Revenue is $99.77M.
| Metric | Value |
|---|---|
| Price | $24.00 |
| Market Cap | $1.09B |
| P/E Ratio | -401.10 |
| EPS | $-0.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.62 |
| 52-Week Low | $17.86 |
| Volume | 947 |
| Avg Volume | 0 |
| Revenue (TTM) | $99.77M |
| Net Income | $-2.96M |
| Gross Margin | 64.96% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $96.21M | $-4.59M | $-0.09 |
| 2023 | $143.27M | $-66.43M | $-1.52 |
| 2022 | $161.76M | $-139.81M | $-3.29 |
| 2021 | $119.16M | $-7.63M | $-0.20 |
6 analysts cover BLFS: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $33.00.